language-icon Old Web
English
Sign In
Acemap > Paper > Evaluation of osimertinib efficacy according to BSA and BMI in patients with NSCLC harboring an EGFR mutation

Evaluation of osimertinib efficacy according to BSA and BMI in patients with NSCLC harboring an EGFR mutation

2019 
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.